Showing results (111-120 of 646) with videos related to

Sort By:
Pageof 65
Hemasphere|December 4, 2023
CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS InvolvementEvgenii Shumilov, Hristo Boyadzhiev, Paolo Mazzeo, et al.
Hemasphere|March 4, 2024
High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphomaMaeve A O'Reilly, Lorna Neill, Simon M Collin, et al.
Hemasphere|March 4, 2024
Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cellsTalia Velasco-Hernandez, Juan L Trincado, Meritxell Vinyoles, et al.
Hemasphere|May 22, 2024
Influence of donor-recipient sex on engraftment of normal and leukemia stem cells in xenotransplantationSyed A Mian, Linda Ariza-McNaughton, Fernando Anjos-Afonso, et al.
Hemasphere|May 22, 2024
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)Fabio Efficace, Rena Buckstein, Gregory A Abel, et al.
Hemasphere|May 28, 2024
Remission after CAR T-cell therapy: Do lymphoma patients recover a normal life?Alya Perthus, Fanny Colin, Emilie Charton, et al.
Hemasphere|May 8, 2024
Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AMLMélanie Lambert, Samy Jambon, Mohamed A Bouhlel, et al.
Hemasphere|September 25, 2023
Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMTFrancesco Saraceni, Myriam Labopin, Anna M Raiola, et al.
Hemasphere|October 9, 2024
Correction to "Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes"
Hemasphere|September 27, 2024
Activating mutations remodel the chromatin accessibility landscape to drive distinct regulatory networks in KMT2A-rearranged acute leukemiaQirui Zhang, Ton Falqués-Costa, Mattias Pilheden, et al.
Pageof 65